School of Medicine
Showing 201-250 of 575 Results
-
Beverly Jazmine Delgado
Research Coordinator, Dermatology
BioI’m a Research Coordinator at Stanford University, with over three years of experience in medical research and technology development. My work at Wipe Out Melanoma - California (WOM-CA) focuses on the importance of healthcare access and levering technology for early detection of melanoma.
I’ve worked in human subject research involving wearable devices and led hands-on training for study procedures, including data collection and handling. With my background in Biomedical Engineering, I’m passionate about applying real-life solutions to modern social and healthcare challenges. I’m skilled in data & project management and fluently speak Spanish. -
Juan Delgado
Casual - Non-Exempt, Epidemiology and Population Health
Current Role at StanfordResearch Assistant - Urologic Cancer Epidemiology Lab
-
Juan Antonio Delgado San Martin
Affiliate, School of Medicine - MDRP'S - Biodesign Program
BioI specialise in computational approaches to uncover insights from large mobile health datasets for cardiovascular risk assessment. I am also interested in survival models, PKPD modelling, language models (including data mining in EHR and genAI), and web app development for other researchers to use. I have extensive experience in industry implementing ML approaches and designing ML-centric industry-scale production software architectures, including MLOps & CICD.
In the academic domain, I share my time between Imperial College London and Stanford research projects. In the industrial domain, I help industrial startups like ValueBase and Aktana —and charities such as Cancer Research UK (CRUK)—extract greater value from advanced data analyses.
The rest of my time is dedicated to teaching companies how to design effective data ecosystems within Google Cloud on behalf of Google. -
Daniel James Delitto, MD, PhD, FACS
Assistant Professor of Surgery (General Surgery)
BioDr. Delitto is a board certified complex general surgical oncologist with a focus on conditions of the liver, pancreas, and stomach. He is an assistant professor in Stanford Medicine’s Department of Surgery.
His education includes a decade of postgraduate training in complex general surgical oncology, as well as a PhD in immunology with an emphasis on cancer biology. He completed a clinical fellowship at Johns Hopkins University and continued his research at the postdoctoral level in the laboratory of Dr. Elizabeth Jaffee. His research focus is on advancing the field of cancer immunology and harnessing his findings to improve immunotherapies.
He was the principal investigator of two studies examining the immune response to pancreatic cancer, including one funded by the National Cancer Institute.
Dr. Delitto has presented the findings of his research at conferences such as the American Association for Cancer Research, Society for the Immunotherapy of Cancer, American Association of Immunologists, American College of Surgeons, Academic Surgical Congress and Pancreas Club. In addition to cancer immunology, he has also presented work focused on cancer cachexia, surgical outcomes, translational experimental models and a variety of other oncologic topics.
He has published original work in Nature Communications, the Journal of the National Cancer Institute, Cancer Research, Clinical Cancer Research, and other high impact journals. He is also a reviewer for Annals of Surgery, Scientific Reports, Surgery, Tumor Biology, Journal of Surgical Research, PLOS ONE, and the Journal of Translational Medicine.
Dr. Delitto has earned numerous honors related to clinical excellence, teaching and research. He is board certified by the American Board of Surgery and a member of the Society of Surgical Oncology, American Association for Cancer Research and American Association of Immunologists. -
Scott L. Delp, Ph.D.
Director, Wu Tsai Human Performance Alliance at Stanford, James H. Clark Professor in the School of Engineering, Professor of Bioengineering and of Mechanical Engineering
Current Research and Scholarly InterestsExperimental and computational approaches to study human movement. Development of biomechanical models to analyze muscle function, study movement abnormalities, design medical products, and guide surgery. Imaging and health technology development. Discovering the principles of peak performance to advance human health. Human performance research. Wearable technologies, video motion capture, and machine learning to enable large-scale analysis.
-
Wendy DeMartini
Professor of Radiology (Breast Imaging)
On Leave from 09/08/2025 To 05/31/2026BioDr. Wendy DeMartini is a Professor in the Department of Radiology at Stanford University School of Medicine. She currently serves as the Associate Chair for Clinical Faculty Affairs in the Department of Radiology, and is the past Division Chief of Breast Imaging. Her work is focused upon high quality patient care, clinical research and education.
Dr. DeMartini completed her fellowship in Breast Imaging at the University of Washington School of Medicine in Seattle, Washington. She then served as Breast Imaging faculty at the University of Washington where she became Associate Professor and Associate Director of Clinical Services, and at the University of Wisconsin where she became Professor and Chief of Breast Imaging.
Dr. DeMartini has more than 100 research presentations, abstracts/publications, review articles or book chapters. Her research is directed toward the appropriate evidence-based use of imaging tests to optimize the detection and evaluation of breast cancer. She has served as an investigator on several studies of breast MRI funded by the National Cancer Institute and by the American College of Radiology Imaging Network (ACRIN). Particular research topics have included the development of a pilot tool for predicting the probability of malignancy of breast MRI lesions, assessment of the impact of background parenchymal enhancement (BPE) on breast MRI accuracy, and evaluation of utilization patterns of breast MRI and other emerging technologies. She also served as the Editor-in-Chief of the Journal of Breast Imaging from 2023 to 2024.
Dr. DeMartini is a highly sought-after educator. She lectures on a broad spectrum of breast imaging topics nationally and internationally, including in the Americas, Europe, Australasia and Africa. She is the past Co-Director of the American College of Radiology (ACR) Education Center Breast MRI with Biopsy Course. Dr. DeMartini is an active member of many professional organizations and committees, including in the Radiologic Society of North America, the American College of Radiology and the Society of Breast Imaging (SBI). She was elected as an SBI Fellow in 2009 and served as President of the SBI in 2017-2018. -
Utkan Demirci
Professor of Radiology (Diagnostic Sciences Laboratory) and, by courtesy, of Electrical Engineering
BioDr. Utkan Demirci, UofM’99, Stanford’01’05’05, is a Professor of Radiology (with tenure) and of Electrical Engineering (by courtesy) at the Canary Center at Stanford for Cancer Early Detection, Stanford University School of Medicine, where he leads a productive researcher group. Utkan is a tenured professor at Stanford University School of Medicine. Prior to joining Stanford in 2014, he held the position of Associate Professor at the Brigham and Women’s Hospital-Harvard Medical School and also served at the Harvard-MIT Health Sciences and Technology division. Over the past decade, his research group has focused on the early detection of cancer and has made significant contributions to the development of microfluidic platforms for sorting rare cells and exosomes and point-of-care bio-sensing technologies.
Dr. Demirci leads a productive and impactful research group focused on addressing problems from the clinic with innovations including cell sorter for IVF, optical technologies for detecting viruses, portable point of care technologies for diagnostics in global health, smart robots in vivo, extracellular vesicle based early detection approaches for cancer. He is an elected fellow of the American Institute of Medical and Biological Engineering and The Academy for Radiology & Biomedical Imaging Research Distinguished Investigator.
He has published over 250 peer-reviewed articles, 300 abstracts and proceedings, 24 book chapters and editorials, and 7 edited books. He also serves on the editorial board of various journals. He is a serial academic entrepreneur and co-founded multiple successful companies. His patents are translated into broadly used biomedical products. Dr. Demirci's pioneering work in microfluidics and cell sorting has resulted in CE certified and FDA approved devices used in over 500,000 clinical cases serving patients globally. -
Megan DeMott, MD
Affiliate, Physician Assistant Studies
BioMegan DeMott, MD, earned dual Bachelor of Arts degrees in Biochemistry and Philosophy from Claremont McKenna College, graduating summa cum laude. She received her medical degree from Johns Hopkins University School of Medicine and completed residency training in Emergency Medicine at Henry Ford Hospital in Detroit, where she served as Chief Resident. She went on to complete a fellowship in Medical Toxicology at the University of California, San Diego.
For the past 15 years, Dr. DeMott has practiced at an indigent care hospital in Brawley, California, where she is dedicated to serving underserved populations. In addition to her clinical work, she mentors Stanford physician assistant students, fostering the next generation of healthcare providers. Her professional interests include medical toxicology, emergency care, and health equity in vulnerable communities. -
Stefania Demuro
Postdoctoral Scholar, Chemical and Systems Biology
BioStefania received her master’s degree in pharmaceutical chemistry from the University of Cagliari (Sardinia, Italy) and later moved to Philadelphia to conduct organic chemistry research at the University of Pennsylvania. Returning to Italy, she completed her Ph.D. in Medicinal Chemistry at the University of Bologna in collaboration with the Italian Institute of Technology, focusing on the development of first-in-class triple protein kinase inhibitors for the treatment of Alzheimer’s disease and related tauopathies (Prof. Andrea Cavalli).
As part of her doctoral training, Stefania spent time at UC San Diego in Prof. Carlo Ballatore’s group, where she developed novel microtubule stabilizers for the treatment of tauopathies.
Drawn to the interconnection between chemistry and biology, and after applying her medicinal chemistry expertise to research in diabetes and neuropathic pain at Stanford ChEM-H, she joined the Chen Lab to investigate the role of ALDH1B1 in tumorigenesis and HIPK4 as a target for male contraception. -
Lyn Denend
Academic Prog Prof Mgr, School of Medicine - MDRP'S - Biodesign Program
Current Role at StanfordDirector for Academic Programs, Stanford Biodesign
Lecturer, Stanford Medicine -
Boxiong Deng
Postdoctoral Scholar, Ophthalmology
BioBoxiong Currently is a postdoctoral fellow in Dr. Sui Wang's lab within Stanford University's Department of Ophathalmology, focusing on the interplay between retinal Müller glial cells and the vasculature in diabetic conditions.
-
Huiqiong Deng, MD, PhD
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Huiqiong Deng is a clinical associate professor of psychiatry. In addition to a medical degree, she earned a PhD, with a major in rehabilitation science and a minor in neuroscience. Specializing in the treatment of alcohol/substance addiction, interventional and cultural psychiatry, her goal is to help each patient along the journey to achieve optimal health and quality of life.
As the co-author of more than a dozen scholarly articles, Dr. Deng’s work has appeared in Psychiatry Research, Journal of Studies on Alcohol and Drugs, American Journal on Addictions, Brain Stimulation, and other publications.
Dr. Deng has won numerous honors and awards such as the National Institute on Drug Abuse Young Investigator Travel Award, the Ruth Fox Scholarship from the American Society of Addiction Medicine, and College on the Problems of Drug Dependence Travel Award for Early Career Investigators. In addition, she was selected to attend the Annual American Psychiatry Association Research Colloquium for Junior Investigators. Since she joined faculty at Stanford, Dr. Deng has received research grant support by the Department of Psychiatry and Behavioral Sciences Innovator Grant Program. -
Jenny Deng
Clinical Research Coordinator Associate, Dermatology
BioJenny Deng is an Assistant Clinical Research Coordinator for Dr. Jean Tang in the Dermatology department. She received her bachelor’s in science from the University of California, Santa Cruz with a major in Molecular and Cell Developmental Biology. She is also a certified phlebotomy technician with an active license. Jenny was born and raised in San Francisco, and when she is not working, enjoys her spare time traveling, working out, and exploring new restaurants to eat.
-
Pujuan Deng
Postdoctoral Scholar, Biochemistry
Current Research and Scholarly InterestsMy research aims to explore the vast genetic diversity of the microbiome, seeking to uncover novel biological mechanisms—like the different ways hosts defend against viral infections.
-
Dr. Qiwen Deng
Postdoctoral Scholar, Pathology
BioMy research aims to understand how immune–stromal interactions shape tissue injury, repair, and fibrosis across chronic diseases. I combine multiplexed spatial proteomics (CODEX), single-cell and spatial transcriptomics, and molecular pathology approaches to dissect the organization and function of complex tissue microenvironments. By mapping spatially resolved cellular neighborhoods in human biopsies, I seek to uncover conserved and disease-specific patterns that can guide biomarker discovery and therapeutic development.
Working within a laboratory focused on the mechanisms and therapeutic targeting of fibrotic diseases, I investigate chronic kidney disease alongside other models of organ fibrosis. With a background spanning molecular biology, therapeutic development, and spatial biology, I aim to advance studies that connect detailed tissue analysis with potential clinical applications. I welcome opportunities for collaborative research in chronic kidney disease and other fibrosis-related conditions.
